Key points 🔹🥱Exhausted kidney IL-7Ra-PD-1+ cells 🔹😡Effector memory kidney IL-7Ra+ T cells 🔹IL-7Ra+ CD4+ & CD8+ cells had much in common 🔹Neutralising the IL-7Ra in active autoimmunity reduced kidney injury 🔹Anti-IL-7Ra mAbs do not kill cells but only neutralise function

Thanks to #vasculitis expert Steve McAdoo speaking @MonashHealth today - and checking out Melbourne on the exact day registration opens for the 2026 International Vasculitis Workshop vasculitis-melbourne2026.com #VasculitisMelbourne2026

Burnet said that his prediction was based at least in part on the work of Jacques Miller, from @WEHI_research

MacFarlane Burnet, 1972: "...the T system of immunocytes will eventually be divided into a number of subgroups on the basis of the types of lymphokine produced." Prescient.

Great day for the lab and especially for the 2 new @Monash_FMNHS PhD graduands - now graduates! @LaniShochet and @nephrologista. High quality theses from outstanding contributors.

Ron Falk, a giant in the field of #vasculitis and nephrology from @UNCKidney, giving the Fokko van der Woude opening plenary lecture at @VasculitisBCN24

New review in @TheLancetRheum - MPO-specific ANCA-associated vasculitis. sciencedirect.com/science/ar… It was great to be able to work with such talented colleagues on this paper - one of a series - just prior to @VasculitisBCN24 Free access to May 21 2024: authors.elsevier.com/c/1isC9…

Thanks @odlerb and colleagues for the opportunity to collaborate and contribute to this excellent review. New and repurposed therapies should soon be coming to immune kidney disease! tinyurl.com/repffsu3

Ben Lazarus, nephrologist, PhD student and @JASN_News Editorial Fellow wins the ANZSN Young Investigator Clinical Award! @MonashUni @SCSMonash @dialysisbloke (supervisor Kevan Polkinghorne)

@nephrologista wins the ANZSN Young Investigator Discovery and Translational Research Award! Fantastic Kate! @SCSMonash @MonashUni @GlomCon

Out now with ⁦⁦@promagnani, @hjanders_hans, Nelson Leung: tinyurl.com/2w9ays3m We propose a new GN classification by cause to ▪️ improve diagnosis/management ▪️ enable better diagnostics/treatments ▪️ help patients/clinicians/researchers understand these complex conditions